Pathology Named Roche Molecular Center of Excellence | GenomeWeb

NEW YORK (GenomeWeb) – Roche said late on Tuesday that Pathology Inc. has become a Roche Molecular Center of Excellence for the next five years.

With the designation, Pathology's molecular diagnostic laboratory will be able to offer molecular technologies from Roche, such as the US Food and Drug Administration-approved cobas HPV test, to physicians and patients. The test helps clinicians assess a patient's risk of cervical cancer based on the presence of clinically relevant high-risk HPV DNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.